Azacitidine Injection shortage
Current 9 presentations · 9 manufacturers · first FDA posting 2020-12-18 · last update 2026-10-15
Manufacturers: Accord Healthcare Inc., Armas Pharmaceuticals Inc, Bristol Myers Squibb Co., Dr. Reddy's Laboratories, Inc., Eugia US LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Meitheal Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Demand increase for the drug; Discontinuation of the manufacture of the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Accord Healthcare Inc. | Current Available |
— | Posted 12/21/2020 Updated 10/03/2026 | |
| Azacitidine, Injection, 100 mg (NDC 72485-201-01) | Armas Pharmaceuticals Inc | Current Limited Availability |
Other | Estimated recovery: TBD | Posted 12/18/2020 Updated 06/08/2026 |
| Vidaza, Injection, 100 mg (NDC 59572-102-01) | Bristol Myers Squibb Co. | Current Available |
— | Posted 12/18/2020 Updated 10/15/2026 | |
| Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Dr. Reddy's Laboratories, Inc. | Current Available |
— | Available to existing customers | Posted 12/18/2020 Updated 09/29/2026 |
| Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 12/22/2020 Updated 10/02/2026 |
| Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Fresenius Kabi USA, LLC | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted 12/18/2020 Updated 10/15/2026 |
| Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 12/18/2020 Updated 09/18/2026 |
| Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted 12/18/2020 Updated 08/27/2026 | |
| Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Teva Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 12/22/2020 Updated 10/15/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)